$1.64
▼ -1.8% Today
as of Aug 5, 16:48 ET
Last 30 days
Recent Press Releases & News
Enveric Biosciences Reports New Preclinical Data Supporting the Non-Hallucinogenic Profile of Lead Candidate EB-003
Enveric Biosciences Welcomes Final FDA Guidance for Psychedelic Drug Development
Enveric Biosciences Announces Participation in B. Riley Securities Mind, Muscle & Vision Summit
Overview
52-week range
$1.71
$18
0% of range
Avg surprise (last 0)
—
Avg reaction (last 2)
-4.9%
0% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Fri May 15, 2026 | Mar/2026 | $-1.08 | — | — | +11.5% | -1.7% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-10.81 | — | — | — | — | financials |
| Thu Aug 14, 2025 | Jun/2025 | $-0.97 | — | — | — | — | earnings |
| Wed May 14, 2025 | Mar/2025 | $-1.22 | — | — | — | -8.1% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-43.10 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-3.72 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-9.21 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-1.30 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-3.04 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Aug 13, 2026 | Jun/2026 | OTHER | — | -$11.64 |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-2M | — | $-2M | $-3M | $-2M | — | $-2M | $-2M |
| Net income | $-2M | — | $-2M | $-3M | $-2M | — | $-2M | $-2M |
| EPS (diluted) | $-1.08 | — | $-10.81 | $-0.97 | $-14.58 | — | $-43.10 | $-3.72 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $5M | $5M | $4M | $3M | $5M | $3M | $4M | $6M |
| Total assets | $6M | $5M | $4M | $4M | $5M | $3M | $5M | $6M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | — | — | — | — | — | — | — | — |
| Total equity | $5M | $4M | $3M | $2M | $4M | $2M | $4M | $5M |
Implied volatility — last 90 days
No IV snapshots yet for ENVB.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.